Sign inGet started

Welch Stephen Andrew

Insider CIK 1944355 · MNK EVP & Head of Spec Generics

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NONE Keenova Therapeutics plc D To issuer deriv2025-11-102025-11-1243,771— $00SEC↗
NONE Mallinckrodt plc A Award deriv2025-07-312025-08-0432,828— $043,771SEC↗
NONE Mallinckrodt plc M Exercise deriv2025-01-012025-01-025,470— $010,943SEC↗
NONE Mallinckrodt plc F Tax w/h2025-01-012025-01-021,839— $03,631SEC↗
NONE Mallinckrodt plc M Exercise2025-01-012025-01-025,470— $05,470SEC↗
NONE Mallinckrodt plc A Award deriv2024-02-022024-02-0616,413— $016,413SEC↗
MNKTQ Mallinckrodt plc D To issuer2023-11-142023-11-1632,686— $00SEC↗
MNK Mallinckrodt plc F Tax w/h2023-08-172023-08-185,859$0.69 $4.0K32,686SEC↗
MNK Mallinckrodt plc D To issuer deriv2023-06-302023-07-0580,754— $00SEC↗
MNK Mallinckrodt plc A Award deriv2023-04-032023-04-0580,754— $080,754SEC↗
MNK Mallinckrodt plc P Buy2023-03-132023-03-151,000$8.48 $8.5K38,545SEC↗
MNK Mallinckrodt plc A Award2022-12-142022-12-2237,545— $037,545SEC↗